Traynor Capital Management, Inc. Iovance Biotherapeutics, Inc. Transaction History

Traynor Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 01, 2022	SELL	$16.55 - $27.63 $167,403 - $279,477	-10,115 Closed	0 $0
Q3 2021 Oct 25, 2021	SELL	$20.35 - $26.63 $40,903 - $53,526	-2,010 Reduced 16.58%	10,115 $249,000
Q2 2021 Jul 21, 2021	SELL	$16.33 - $33.07 $13,880 - $28,109	-850 Reduced 6.55%	12,125 $320,000
Q1 2021 May 04, 2021	BUY	$28.67 - $52.59 $371,993 - $682,355	12,975 New	12,975 $410,000

313

237M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.18B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Traynor Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Traynor Capital Management, Inc. with notifications on news.